Stanford Investment Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-400
Closed -$28K 169
2016
Q4
$28K Hold
400
0.01% 207
2016
Q3
$35K Hold
400
0.02% 192
2016
Q2
$35K Sell
400
-155
-28% -$12.5K 0.02% 183
2016
Q1
$42K Buy
555
+155
+39% +$11.7K 0.02% 156
2015
Q4
$31K Sell
400
-209
-34% -$15.7K 0.02% 176
2015
Q3
$41K Hold
609
0.03% 133
2015
Q2
$45K Hold
609
0.03% 135
2015
Q1
$47K Hold
609
0.04% 137
2014
Q4
$44K Buy
+609
New +$42.3K 0.04% 148

Other funds holding MDT

Stanford Investment Group's MDT Position: Q1 2017 in Review

Stanford Investment Group sold out of Medtronic (MDT) in Q1 2017, closing a stake of 400 shares — an estimated $28K sold.

Stanford Investment Group first reported a position in MDT in Q4 2014 and held it in 9 quarters. The position peaked at $47K in Q1 2015. 1,284 funds tracked by Wall St. Rank hold MDT as of Q1 2017.

  • Stanford Investment Group reported no remaining Medtronic position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 400 Medtronic shares in Q1 2017, an estimated $28K.
  • Stanford Investment Group first reported a position in Medtronic in Q4 2014 and held it in 9 quarters.
  • Stanford Investment Group's Medtronic position peaked at $47K in Q1 2015.
  • 1,284 funds tracked by Wall St. Rank held Medtronic as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.